SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Ionis Pharmaceuticals (IONS)
An SI Board Since May 1996
Posts SubjectMarks Bans Symbol
4676 121 0 IONS
Emcee:  Keith Fauci Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
3251Isis Pharmaceuticals Initiates European Phase III Clinical Trial Of Alicaforsen,Elmer-6/25/2002
3250>>SAN DIEGO & INDIANAPOLIS--(BW HealthWire)--June 18, 2002--Isis Pharmtuck-6/18/2002
3249Details of Elan filing: sec.gov Might as well post the convertible filing, tootuck-6/12/2002
3248Jim McCamant (Med Tech Stock letter) comments in BW online (today i think). &qubob zagorin-6/12/2002
3247Spencer R. Berthelsen, M.D., F.A.C.P., Elected to Isis Pharmaceuticals' Boarbob zagorin-6/11/2002
32462:30PM ISIS Pharm rises on stock sale clarification (ISIS) 8.32 +0.17: ISIS postSemiBull-6/6/2002
3245Protein Phosphatases Drug Discovery Conference to Feature Latest Industry & bob zagorin-6/6/2002
3244the presentation on the web site from yesterday is quite interesting. crooke agrbob zagorin-6/1/2002
3243The market cap isn't a lot more than the value of the Lilly deal. Go figure.Elmer-6/1/2002
3242ASCO commentary from Bull Market Bio investor ISIS PHARMACEUTICALS (ISIS, $10, bob zagorin-5/31/2002
3241Isis Pharmaceuticals, Inc. Open House Presentation CARLSBAD, Calif., May 29 /PRSemiBull-5/30/2002
3240Issuance of Pivotal Patent Provides Isis Pharmaceuticals Therapeutic Control OveSemiBull-5/29/2002
3239Is anyone going to the shareholder meeting Friday? I invest mostly in San DiegoMr. Sunshine-5/28/2002
3238reiterated today ISIS Pharm ISIS Needham & Co Strong Buybob zagorin-5/28/2002
3237Isis Pharmaceuticals Expands Therapeutic Potential of Antisense Technology To Cabob zagorin-5/21/2002
3236New Affinitac(TM) Data in Non-Small Cell Lung Cancer Presented at ASCO ORLANDO,nigel bates-5/20/2002
3235I think the worst is over. If the technology works and the PIII trials are succeElmer-5/13/2002
3234David You are very right. Have the shorts finished or are we in for more. IrMJ-5/13/2002
3233The Drug Designer Stanley Crooke is pursuing a completely new way of making medmopgcw-5/13/2002
3232Isis Pharmaceuticals Announces Pricing of Convertible Subordinated Notes CARLSBSemiBull-4/28/2002
3231<Yes this dilutes common shares ultimately making more shares available on thElmer-4/27/2002
3230Retiring the 14% interest debt makes sense from a business stand point imo. YeMJ-4/26/2002
3229Isis Pharmaceuticals Achieves $3.75 Million Development Milestone In HepaSense JSemiBull-4/25/2002
3228<i>These are the same guys that took $125 million off the market cap of thtom pope-4/24/2002
3227<Amazing that the cfo of a company with a market cap approaching $1bn doesn&#Elmer-4/24/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News